Obstructive sleep apnea and cardiometabolic risk

• Auteurs principaux: Vekić Jelena (Auteur), Jelić-Ivanović Zorana (Auteur), Zeljković Aleksandra (Auteur), Stefanović Aleksandra (Auteur), Spasojević-Kalimanovska Vesna (Auteur)
• Format: Livre
• Publié: Pharmaceutical Association of Serbia, Belgrade, Serbia, 2019-01-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Obstructive sleep apnea (OSA) is a chronic, progressive disorder with a high prevalence in the population. Without timely diagnosis and therapy OSA can significantly affect the quality of life of the patients. OSA is a common co-morbidity in patients with metabolic syndrome (MS) and cardiovascular d...